Summary The effect of selected marine compounds with anti-tumoral activity on the cell microtubule network was tested by immunofluorescence analyses, or by other in vitro analyses involving competition with colchicine or with GTP for tubulin binding and tubulin polymerisation, studies that were carried out in parallel with other microtubule poisons used as controls. Three compounds were found to disorganise the microtubule network: isohomohalichondrin B, LL-15 and ecsteinascidin 743. The first two compounds prevent microtubule assembly and GTP binding to tubulin. Ecteinascidin 743 disorganises the microtubule network but it does not seem to interact directly with tubulin.
Microtubules are tubulin polymers involved in different functions, including the determination of cell morphology, the regulation of intracellular organisation or to facilitate chromosome segregation, which takes place during the process of cell division. Thus, compounds that interfere with the mechanism of microtubule polymerisation could inhibit assembly of the mitotic spindle and consequently could prevent cell division. This characteristic has been taken into account when identifying those compounds as antitumoral agents. Different natural and synthetic compounds have been used as anti-tumoral drugs based on their ability to affect the microtubule polymerisation-depolymerisation process (Rowinsky and Donehower, 1991; Hamel, 1990; Diez et al., 1987; Luduefia et al., 1989; Bai et al., 1991; Sullivan et al., 1990; Huang et al., 1985; Hoeberek et al., 1976; Wheeler et al., 1982; Schiff et al., 1979) . Different mechanisms have been postulated for the action of different microtubule poisons. Some of those compounds prevent microtubule polymerisation by binding to tubulin in a similar way to colchicine, the first compound described to affect microtubule assembly (Taylor, 1965) . Other compounds interfere with the binding of GTP to tubulin (Bai et al., 1991) . Also, the presence of certain microtubule-associated proteins, which could be different in cells of different origin, could modulate the action of microtubule inhibitors (Boas et al., 1994) . As different tumour cells may be resistant to some of those microtubule poisons (Beck, 1987) , a search for novel compounds from new sources should be carried out.
Natural antimicrotubular compounds mainly originate from plant or fungi, and they usually show their inhibitory effect in the range of 10 -6M (Hamel, 1990) . Synthetic or semi synthetic compounds have also been used. An example is nocodazol (Hoeberek et al., 1976) . In this work we tested a family of compounds from marine animals, as those animals have been indicated as a source for microtubule poisons (Bai et al., 1991) that could interfere with cell proliferation (Flam, 1994) . Additionally, a semisynthetic product, LL-15 (Gordaliza et al., 1996) , with a structure related to podophylotoxin, a microtubule poison (Hamel, 1990) , was tested. Our results indicate that three of the tested compounds alter the cell microtubule network at a low concentration range.
These compounds are isohomohalichondrin B (from the sponge Lissodendoryx sp, with activity in lung cancer or melanoma cell lines), (Hirata and Uemura, 1986) , ecteinascidin 743 (from the tunicate Ecteinascidia turbinata, also with activity in lung cancer and in breast cancer and melanoma cell lines) and the compound LL-15. In this study we characterised the antimitotic effect of these compounds.
Materials and methods Chemicals and antibodies
Colcemid (demecolcine) and nocodazole were obtained from Sigma. Ring A-4-[3H]colchicine and [8-3H]GTP (specific activity 1 mCi mmol-and 7.7 Ci mmol-respectively) were from Amersham. Isohomohalichondrin B, ecteinascidin 743, LL-15 and the other marine compounds (digonozate triacetate, Palau's amine, thiocoraline, benzoascidermin, MB-3 and mycoperoxide B) were provided by PharmaMar. The structures of some of these compounds and those of some isomers are shown in Figure 1 . Stock solutions of these drugs were made in dimethyl sulphoxide (DMSO) and stored at -20°C. Anti-tubulin, anti-actin and anti-vimentin monoclonal antibodies and fluorescein or Texas red-labelled goat anti-mouse immunoglobulins were from Amersham.
Cell culture COS-1 (Gluzman, 1981) , HeLa or mouse P388 cells were grown in Dulbecco's modified Eagle medium supplemented with 5% fetal bovine serum. Cells were plated onto 10 x 10 mm coverslips in 24-well tissue culture plates at a density of 100 cells mm-2 and cultured for 1 day. The cells were then treated with different concentrations of the drugs for 2 -24 h. After the treatment, in selected cases, the culture medium containing the drug was removed and fresh medium was added to allow cell recovery. 
Immunofluorescence analysis
The coverslips with treated cells were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) (w/v) (Osborn and Weber, 1982) . Preparations were washed twice with PBS, treated with sodium borohydride ( 1 mg ml-') and permeabilised with 0.2% Triton X-100. The coverslips were washed with 1% bovine serum albumin (BSA) in PBS (w/v). Afterwards, the cells were overlaid for 1 h at room temperature with 20 ,ul of mouse monoclonal anti-a-or anti ,B-tubulin antibodies diluted 1:1000 in PBS-BSA 1% (w/v). After washing with PBS, coverslips were overlaid with fluorescein or Texas red-labelled goat anti-mouse antibodies diluted 1:50 in PBS-BSA 1%. The coverslips were mounted with Mowiol and stored in the dark at 4°C until observation.
Negative controls were routinely prepared by omitting the first antibody. These typically gave a weak fluorescence (requiring about ten times more exposure time) that was distributed diffusely within the cells.
Microtubule protein preparation Microtubules were purified from bovine brain as described previously by Karr et al. (1982) . Tubulin depleted of microtubule-associated proteins was isolated from microtubules by phosphocellulose chromatography (Weingarten et al., 1975) .
Microtubule polymerisation
Microtubule protein (2 mg ml-') was incubated in the absence or presence of different concentrations of drugs in a buffer containing 80 mM Pipes (pH 6.9), 1 mM magnesium chloride, 1 mM EGTA, 1 mM GTP and DMSO 10% for 30 min at 35°C. The use of DMSO to facilitate microtubule assembly was described previously in the pioneer work of Himes et al. (1977) . The polymerised protein was pelleted in a Beckman airfuge for 5 min at maximum speed at room temperature, and quantified by electrophoresis. The same assay was performed with tubulin depleted of associated proteins.
Colchicine binding assay The colchicine binding activity of purified brain tubulin was measured as reported by Sherline et al. (1974) . The assay was performed as follows: 50 Mg of microtubule protein (1 mg ml-') in MES 100 mM (pH 6.4), 0.5 mM magnesium chloride and 2 mM EGTA (buffer A), were incubated with 10-6M [3H]colchicine (1 mCi mmol-1) in the absence or presence of drug for 90 min at 35°C in the dark. Equilibrium was attained after 30 min at the protein concentrations used in the assay. After incubation, 0.5 ml of activated charcoal solution (6 mg ml-') in buffer A was added and incubated for 10 min at 4°C. The samples were then centrifuged in a microfuge for 10 min at 4°C. The supernatant was collected and the radioactivity measured after the addition of 5 ml of Scintillation Cocktail Optiphase 'Hisafe' (Wallac). In some cases morphological changes were observed upon treatment with the last three compounds, therefore they were tested as possible inhibitors of microtubule assembly. Figure  1 shows that DT, PA, T, B, MB-3 and MB do not change the microtubule network as determined by immunofluorescence analyses. On the other hand, IHB and LL-15 disrupt the microtubule cytoskeleton, whereas the presence of ET 743, under the described conditions (see legend to Figure 2 ) slightly decreases the number of fibres present in the cell microtubule network. As a positive control, the effect of a known microtubule inhibitor, nocodazole (Hoeberek et al., 1976) , on the microtubule network is also indicated (Figure  2) .
The effect of IHB on cell microtubule assembly is not surprising as it has been reported that an isomer of that compound, homohalichondrin B, inhibits microtubule assembly in vitro (Bai et al., 1991) . When a similar in vitro analysis was done using IHB it was observed that it also inhibits in vitro microtubule assmebly. Tubulin polyermerisation was inhibited by 50% by the addition of 3 gUM nocodazole, or by 2 tM IHB by using the DMSO-induced assembly procedure described in Materials and methods. An example of this analysis is given in Figure 3 , in which the proportion of assembled tubulin in the absence (control) or presence of nocodazole (used as positive control of assembly inhibition) or IHB is shown. A difference between the drugs is the time for the reversion of the poison effect, which takes longer for IHB than for nocodazole (Figure 4) . Another difference was the IHB inhibition of in vitro microtubule assembly was not prevented by the presence of microtubule-associated proteins (data not shown). This has also been reported for homohalichondrin B (Bai et al., 1991 Table I ). However, it has little effect on GTP binding to tubulin ( Figure 5 ). This result may be explained by the LL-15 structural homology with podophyllotoxin, a compound that has the above characteristics with respect to interference with colchicine binding to tubulin.
Less clear is the effect of ecteinascidin 743 on the microtubule network. Immunofluorescence analysis ( Figure  6 ) indicates a dramatic rearrangement of the microtubule network on cultured COS-1 cells when a long incubation with ET 743 was performed (compare Figures 2 and 6 ). Different effects could be observed on microtubule organisation, with increasing drug treatment time or drug concentration. First, there was a decrease in the proportion of assembled microtubules at the cell cytoplasm (Figure 2e) , followed by the appearance of microtubule bundles around the nuclear membrane ( Figure 6 ). Subsequently, the appearance of microtubule bundles in other cell localisations were observed ( Figure 6 ). Those cells treated under the conditions in which microtubule bundles around the nuclear membrane were observed were unable to recover when the drug was washed out. A similar but less pronounced effect was found when two isomers of ET (Figure 7) . When HeLa cells were tested with ET 743 the same effects were observed as for COS-l cells.
The effect of ET 743 on in vitro microtubule assembly was tested as described above for IHB. In this case at concentrations of 1 /uM, 3 1UM and 7 ,UM, assembly was Possible interference of ET 743 with GTP binding to tubulin was analysed. Figure 5 indicates that ET 734 did not decrease the GTP binding to tubulin. No effect on the microfilament network was observed when the cells were treated with IHB or the ecteinascidin isomers. Also, no significant differences were found in the intermediate filament network, although filaments are predominantly located around the cell nucleus (Figures 8 and 9 ). Figure 8 shows that in the presence of IHB the major cytoskeletal differences were observed for the microtubule network but not for the microfilament, or intermediate filament organisation, despite the localisation of intermediate filaments being mainly around the cell nucleus. Figure 9 indicates that cell treatment for ET 743 (Flam, 1994) . These compounds prevent microtubule assembly by different mechanisms. Some of them, such as nocodazole, have an effect similar to that of colchicine and may compete with this drug for its binding to tubulin (Hamel, 1990) . Other compounds may interfere with GTP binding to tubulin and inhibit the binding of other microtubule poisons, such as vinca alkaloids to tubulin (Hamel, 1990; Bai et al., 1991) .
In the present work three new marine compounds have network by direct interaction with tubulin, resulting in the decreased binding of GTP to the protein, essential for tubulin polymerisation. This result, indicating the mechanism of action of IHB on microtubule protein, is consistent with results of other isomers of this drug and related drugs (Bai et al., 1991; 1990) . Also, LL-1 5 behaves like its structural homologue podophyllotoxin with respect to its interference with colchicine binding (Wilson, 1970; Hamel, 1990 (Klymkowsky, 1981) .
In summary, three different compounds, from marine organisms, show different effects on microtubule organisation. IHB interferes with GTP binding to tubulin, probably acts on tubulin in the same way as podophyllotoxin (see Hamel, 1990) and ET 743 has a novel effect on microtubule distribution in cultured cells. The mechanism of action of ET 743 appears different to those previously described for microtubule inhibitors.
